Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
3.45
-0.09
(-2.54%)
USD |
NASDAQ |
Sep 09, 13:58
Shuttle Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 3.346M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.346M |
| December 31, 2025 | 2.254M |
| September 30, 2025 | 1.394M |
| June 30, 2025 | 3.606M |
| March 31, 2025 | 3.285M |
| December 31, 2024 | 0.7092M |
| September 30, 2024 | -1.315M |
| June 30, 2024 | 0.8014M |
| March 31, 2024 | 2.762M |
| Date | Value |
|---|---|
| December 31, 2023 | 4.056M |
| September 30, 2023 | 5.610M |
| June 30, 2023 | 6.936M |
| March 31, 2023 | 6.906M |
| December 31, 2022 | 7.678M |
| September 30, 2022 | 8.405M |
| June 30, 2022 | -2.306M |
| March 31, 2022 | -1.850M |
| December 31, 2021 | -1.628M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.81M |
| Total Liabilities (Quarterly) | 8.463M |
| Debt to Equity Ratio | 0.064 |
| Current Ratio | 0.2965 |
| Net Debt Paydown Yield | 5.09% |